Jill K. MacAlpine, Ph.D.

Past Its Peak: Freedom to Operate, Inc. Fails to Persuade PTAB to Institute Two Post-Grant Reviews for Patents Covering Psilocybin

USA - July 27 2022 In Freedom to Operate, Inc. v. Compass Pathfinder Ltd., the Patent Trial and Appeal Board (“the PTAB”) denied the institution of post-grant review…

Thomas L. Irving, Stacy Lewis, Emma N. Ng, Shannon M. Patrick

ANDA Specification Controls Infringement Analysis, Not Expert Testimony

USA - March 10 2022 In Exela Pharma Scis., LLC v. Eton Pharms., Inc., No. 20-cv-365 (D. Del. Feb. 8, 2022), the District Court for the District of Delaware granted…

Thomas L. Irving, Stacy Lewis, Shannon M. Patrick, Paul W. Browning Ph.D., Melissa C. Santos, Ph.D., Troy Viger

“Show More of You”: Amgen v. Sandoz, Battling it Out on Amgen’s Otezla® Drug

USA - January 18 2022 In the Hatch-Waxman patent infringement case Amgen, Inc. v. Sandoz Inc., Civ. Action No. 3:18-cv-11026, Judge Shipp of the District Court of New…

Thomas L. Irving, Hira Javed, Stacy Lewis, Paul W. Browning Ph.D., Melissa C. Santos, Ph.D.

A Mixed Bag: Some Claims Found Unpatentable but Others Are Patentable

USA - November 15 2021 In Liquidia Technologies, Inc. v. United Therapeutics Corp., IPR2020-00770, Paper 45 (P.T.A.B. Oct. 8, 2021), the Patent Trial and Appeal Board…

Thomas L. Irving, Hira Javed, Stacy Lewis, Amanda K. Murphy, Melissa C. Santos, Ph.D.

Patent Trial and Appeal Board Releases Updated Orange Book/Biologic Patent Study

USA - October 20 2021 On Aug. 11, 2021, the United States Patent and Trademark Office (USPTO) published an update to its 2019 Orange Book (OB) patent/biologic patent study…